ACT vs ESNT

ACT's Piotroski F-Score of 4/9 indicates weak financial health, signaling potential operational inefficiencies despite strong profitability. The absence of an Altman Z-Score raises concern about default risk, especially given the sector's average debt levels. While the company trades below its Graham Number ($61.88) and intrinsic value ($133.34), its current price of $40.49 reflects a significant discount, likely due to low growth and weak financial stability signals. Insider selling activity over the past six months adds bearish sentiment, and analyst consensus remains at 'hold' with limited upside. The stock's strong historical earnings surprises and high margins are offset by stagnant revenue growth and elevated peer P/E multiples.

ESNT presents a classic value trap profile: fundamentally sound with a stable Piotroski F-Score of 4/9 and an exceptionally strong balance sheet, yet plagued by stagnant growth and bearish internal signals. While the Graham Number of $96.76 suggests significant defensive undervaluation, the intrinsic value of $57.62 and negative Q/Q growth trends indicate a lack of catalysts. The company maintains high margins and low debt, but recent earnings misses and consistent insider selling offset the attractive valuation metrics.